Fig. 4.

GSK-3β inhibition induces G2/M accumulation in Neuro-2A. Neuro-2A cells were treated with GSK-3β inhibitor SB415286 (25 μM) or DMSO and collected after 24, 48, 72 and 96 h, stained with and PI and analyzed by flow cytometry. Shown are a representative diagrams of distribution of stained cells and b bar graph of the average change in the percent G1G0, S-phase and G2M cells in each treatment with SEM of three experiments; *P < 0.05 (h)